drugset / Trial / NCT01389479
Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of the study is to evaluate the safety, tolerance and immunogenicity of Fluviral™ in healthy adults aged 18-64 years.
Timeline
- Start
- 2005-01
- Primary completion
- 2005-05
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluviral | Vaccine | — | Intramuscular |
| Comparator | Influenza Virus Vaccine | Vaccine | — | Intramuscular |